Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Piperidolate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 known ✓ | P08172 | 5/20 | 0.50 |
| ▸ | CHRM1 known ✓ | P11229 | 5/20 | 0.50 |
| ▸ | CHRM3 known ✓ | P20309 | 5/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.95 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.95 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.95 |
| ▸ | HTT | P42858 | 1/20 | 0.68 |
| ▸ | TP53 | P04637 | 1/20 | 0.54 |
| ▸ | PKM | P14618 | 1/20 | 0.54 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.54 |
| ▸ | THPO | P40225 | 1/20 | 0.54 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 3/20 | 0.53 |
| ▸ | THRB | P10828 | 3/20 | 0.53 |
| ▸ | BLM | P54132 | 3/20 | 0.53 |
| ▸ | PMP22 | Q01453 | 3/20 | 0.53 |
| ▸ | MEN1 | O00255 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | GMNN | O75496 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Piperidolate SCHEMBL28832658 | 0.98 | CYP2D6 (1.00) | CYP2D6CYP3A4CYP1A2HTTTP53 | |
| Piperidolate SCHEMBL249131 | 0.98 | CYP2D6 (1.00) | CYP2D6CYP3A4CYP1A2HTTTP53 | |
| Piperidolate SCHEMBL2734595 | 0.96 | CYP2D6 (0.98) | CYP2D6CYP3A4CYP1A2HTTTP53 | |
| Piperidolate SCHEMBL437741 | 0.96 | CYP3A4 (1.00) | CYP2D6CYP3A4CYP1A2HTTTP53 | |
| SCHEMBL14128808 | 0.90 | CYP2D6 (0.86) | CYP2D6CYP3A4CYP1A2HTTTP53 | |
| SCHEMBL14125434 | 0.90 | CYP2D6 (0.86) | CYP2D6CYP3A4CYP1A2HTTTP53 | |
| SCHEMBL24671287 | 0.84 | CYP3A4 (0.76) | CYP2D6CYP3A4CYP1A2HTTTP53 | |
| SCHEMBL7588607 | 0.82 | CYP2D6 (0.73) | CYP2D6CYP3A4CYP1A2HTTTP53 | |
| SCHEMBL24671171 | 0.81 | CYP2D6 (1.00) | CYP2D6CYP3A4CYP1A2HTTTP53 | |
| SCHEMBL10517675 | 0.78 | CYP2D6 (0.70) | CYP2D6CYP3A4CYP1A2HTTTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190336490-A1 | COMPOSITIONS AND METHODS FOR INCREASING REMYELINATION | Frequency Therapeutics, Inc. | 2019-11-07 | — | — | US | disclosed |
| EP-2554184-B1 | PREVENTIVE AND/OR REMEDY FOR HAND AND FOOT SYNDROME | ONO PHARMACEUTICAL CO (JP) | 2016-10-26 | — | — | EP | disclosed |
| US-8729056-B2 | Preventive and/or therapeutic agent of hand-foot syndrome | ONO PHARMACEUTICAL CO., LTD. (JP) | 2014-05-20 | — | — | US | disclosed |
| US-20130045956-A1 | PREVENTIVE AND/OR THERAPEUTIC AGENT OF HAND-FOOT SYNDROME | ONO PHARMACEUTICAL CO., LTD. (JP) | 2013-02-21 | — | — | US | disclosed |
| EP-2554184-A1 | PREVENTIVE AND/OR REMEDY FOR HAND AND FOOT SYNDROME | ONO Pharmaceutical Co., Ltd. (JP) | 2013-02-06 | — | — | EP | disclosed |
| US-7927613-B2 | Pharmaceutical co-crystal compositions | UNIVERSITY OF SOUTH FLORIDA (US) | 2011-04-19 | — | — | US | disclosed |
| US-7790905-B2 | Pharmaceutical propylene glycol solvate compositions | MCNEIL-PPC, INC. (US) | 2010-09-07 | — | — | US | disclosed |